Stock CENBF CEN BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials CEN Biotech, Inc.

Equities

CENBF

CA15130L1040

Market Closed - OTC Markets
Other stock markets
 12:50:25 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.0031 USD 0.00% Intraday chart for CEN Biotech, Inc. 0.00% +3.33%
2023 CEN Biotech, Inc. Announces Resignation of Lawrence Lehoux as a Member of the Board and Chief Technology Officer CI
2022 CEN Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI

Valuation

Fiscal Period: December 2016 2017 2018 2019 2020 2021
Capitalization 1 14.35 14.35 14.35 14.35 14.35 11.2
Enterprise Value (EV) 1 27.88 31.77 33.5 34.84 25.69 16.55
P/E ratio -2.22 x -1.22 x -6.89 x -9.56 x 4.52 x -0.47 x
Yield - - - - - -
Capitalization / Revenue - - - - - 17,873,214 x
EV / Revenue - - - - - 26,400,426 x
EV / EBITDA -26.4 x -2.84 x -12.6 x -16.3 x -14.5 x -0.96 x
EV / FCF -418 x 12.3 x 58.6 x 29.6 x -2.5 x 2.68 x
FCF Yield -0.24% 8.15% 1.71% 3.38% -40% 37.3%
Price to Book -1.61 x -2.71 x -2.46 x -2.16 x -5.65 x -7.09 x
Nbr of stocks (in thousands) 7,000 7,000 7,000 7,000 7,000 53,353
Reference price 2 2.050 2.050 2.050 2.050 2.050 0.2100
Announcement Date 4/13/17 4/16/18 4/16/19 4/14/20 3/12/21 4/14/22
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2016 2017 2018 2019 2020 2021
Net sales - - - - - 0.6269
EBITDA 1 -1.054 -11.19 -2.662 -2.137 -1.772 -17.16
EBIT 1 -1.1 -11.61 -3.101 -2.58 -2.208 -17.63
Operating Margin - - - - - -2,811.72%
Earnings before Tax (EBT) 1 -7.582 -14.08 -7.53 -5.655 14.25 -18.94
Net income 1 -7.582 -14.08 -7.53 -5.655 14.25 -18.9
Net margin - - - - - -3,015.58%
EPS 2 -0.9221 -1.675 -0.2976 -0.2145 0.4532 -0.4500
Free Cash Flow 1 -0.0667 2.59 0.5716 1.176 -10.27 6.181
FCF margin - - - - - 985.99%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/13/17 4/16/18 4/16/19 4/14/20 3/12/21 4/14/22
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2016 2017 2018 2019 2020 2021
Net Debt 1 13.5 17.4 19.1 20.5 11.3 5.35
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -12.83 x -1.557 x -7.194 x -9.591 x -6.401 x -0.3114 x
Free Cash Flow 1 -0.07 2.59 0.57 1.18 -10.3 6.18
ROE (net income / shareholders' equity) 79% 85.2% 37.4% 24.2% -80.2% 325%
ROA (Net income/ Total Assets) -11.1% -83.2% -23.7% -22.1% -20.3% -149%
Assets 1 68.31 16.92 31.74 25.62 -70.28 12.66
Book Value Per Share 2 -1.270 -0.7600 -0.8300 -0.9500 -0.3600 -0.0300
Cash Flow per Share 2 0.0100 0 0 0 0 0
Capex - 0.16 0.01 - - 0.02
Capex / Sales - - - - - 3.7%
Announcement Date 4/13/17 4/16/18 4/16/19 4/14/20 3/12/21 4/14/22
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. CENBF Stock
  4. Financials CEN Biotech, Inc.